Literature DB >> 9461514

Identification and localization of myosin phosphatase in human platelets.

A Murányi1, F Erdodi, M Ito, P Gergely, D J Hartshorne.   

Abstract

Type 1 (PP1) and type 2A (PP2A) phosphatase activity was measured in three subcellular fractions of human platelets. About 80% of the activity was in the high-speed supernatant. Western blots showed that the catalytic subunit of PP1 (PP1c), including alpha- and delta-isoforms, was present in each fraction, but the level of the catalytic subunit of PP2A was very low in the low-speed pellet (cytoskeletal fraction). Various antibodies detected a subunit similar to the 130 kDa subunit (M130) of myosin phosphatase (MP) of smooth muscle in the low- and the high-speed pellets of human platelets. PP1c and associated proteins were isolated by microcystin-Sepharose. Many proteins were separated from each fraction, including myosin, actin and PP1c. M130 was separated only from the low-speed and the high-speed pellets. Kinase activities were detected in the unbound fractions, and fractions from the low- and high-speed pellets phosphorylated M130 and myosin respectively. Treatment of platelets with calyculin A increased the phosphorylation level of many proteins, including myosin heavy- and light-chains, and caused association of cytoskeletal proteins with the low-speed pellet. No marked change in the distribution of PP1c and M130 was detected. These results suggest that the MP in human platelets is composed of PP1c plus a subunit similar to M130 of the smooth muscle phosphatase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461514      PMCID: PMC1219131          DOI: 10.1042/bj3300225

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Purification and characterization of three distinct types of protein phosphatase catalytic subunits in bovine platelets.

Authors:  F Erdödi; C Csortos; L Sparks; A Murányi; P Gergely
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

2.  The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1.

Authors:  D Alessi; L K MacDougall; M M Sola; M Ikebe; P Cohen
Journal:  Eur J Biochem       Date:  1992-12-15

3.  The inhibitory effects of okadaic acid on platelet function.

Authors:  M Higashihara; K Takahata; K Kurokawa; M Ikebe
Journal:  FEBS Lett       Date:  1992-07-28       Impact factor: 4.124

4.  Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid.

Authors:  K M Lerea
Journal:  Biochemistry       Date:  1991-07-16       Impact factor: 3.162

Review 5.  The platelet cytoskeleton.

Authors:  J E Fox
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

6.  A regulatory subunit of smooth muscle myosin bound phosphatase.

Authors:  S Okubo; M Ito; Y Takashiba; K Ichikawa; M Miyahara; H Shimizu; T Konishi; H Shima; M Nagao; D J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

Review 7.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

8.  The 204-kDa smooth muscle myosin heavy chain is phosphorylated in intact cells by casein kinase II on a serine near the carboxyl terminus.

Authors:  C A Kelley; R S Adelstein
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

9.  Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.

Authors:  M Nishikawa; H Toyoda; M Saito; K Morita; I Tawara; K Deguchi; T Kuno; H Shima; M Nagao; S Shirakawa
Journal:  Cell Signal       Date:  1994-01       Impact factor: 4.315

10.  Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.

Authors:  F Erdödi; B Tóth; K Hirano; M Hirano; D J Hartshorne; P Gergely
Journal:  Am J Physiol       Date:  1995-11
View more
  8 in total

Review 1.  Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

Authors:  A P Somlyo; A V Somlyo
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

2.  Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma.

Authors:  L Maródi; K Goda; A Palicz; G Szabó
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton.

Authors:  Eniko Kiss; Andrea Murányi; Csilla Csortos; Pál Gergely; Masaaki Ito; David J Hartshorne; Ferenc Erdodi
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

4.  Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.

Authors:  László Márkász; György Hajas; Andrea Kiss; Beáta Lontay; Eva Rajnavölgyi; Ferenc Erdodi; Eva Oláh
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

5.  Interaction of protein phosphatase 1δ with nucleophosmin in human osteoblastic cells.

Authors:  Tatsuji Haneji; Jumpei Teramachi; Kanji Hirashima; Koji Kimura; Hiroyuki Morimoto
Journal:  Acta Histochem Cytochem       Date:  2011-11-05       Impact factor: 1.938

6.  Activation of myosin phosphatase targeting subunit by mitosis-specific phosphorylation.

Authors:  G Totsukawa; Y Yamakita; S Yamashiro; H Hosoya; D J Hartshorne; F Matsumura
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

7.  The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.

Authors:  Renáta Hudák; János Vincze; László Csernoch; Ildikó Beke Debreceni; Tamás Oláh; Ferenc Erdődi; Kenneth J Clemetson; János Kappelmayer
Journal:  Biomed Res Int       Date:  2017-06-07       Impact factor: 3.411

8.  Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.

Authors:  Benjamin Aj Reddi; Samantha M Iannella; Stephanie N O'Connor; Adam M Deane; Scott R Willoughby; David P Wilson
Journal:  Intensive Care Med Exp       Date:  2015-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.